BioSpace News Archive

- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today announced that John Houston, Ph.D., President and Chief Executive Officer, will present a keynote plenary session at the 3rd Annual Targeted Protein Degradation Summit being held virtually October 14-15, 2020. The presentation will reflect on Arvinas’ advances in its PROTAC® platform and introduce new

MedTech Innovator, the largest accelerator of medical devices in the world, today announced Rhaeos as the winner of its 2020 Global Competition. The winning company was determined by a virtual live audience vote on October 6 during The Virtual MedTech Conference, powered by AdvaMed.

Cook Medical announced that the U.S. Centers for Medicare and Medicaid Services has granted a new technology add-on payment for Hemospray® Endoscopic Hemostat.

This $135,000 Was Structured as a Non-Convertible Promissory Note, With 6-Month Grace Period, to be Repaid in 7 Equal Monthly Installments (April 5, 2021 thru October 5, 2021) NEW YORK, NY, Oct. 06, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating, diversified life sciences company, with a proprietary line of functional “supplement” chewing gums (Flavors: Pomegranate, Blood Orange, Peach-Lemon, Pear

Sienna Senior Living Inc. (“Sienna” or the “Company”) (TSX: SIA) announced that it will report its 2020 third quarter results after market close on Wednesday, November 11, 2020.

Spartan Medical Inc., a Service-Disabled Veteran-Owned Small Business founded in 2008, is proud to announce its strategic partnership with NavCare, LLC, to create the AMERICAN HERO Virtual Care Management Program.

Program offers more convenience for blood stem cell donors, more reliability for patients and physicians

A hotter than average1 summer has factored into more severe2 ragweed allergy conditions which, combined with poor air quality caused by the vast and tragic West Coast wildfires, has asthma sufferers across the country feeling the impact of a harsh fall season.

Ellume , the company reimagining digital diagnostics, today announced a $30 million Phase 2 award from the U.S. National Institutes of Health (NIH)’s Rapid Acceleration of Diagnostics (RADx) initiative to accelerate the clinical testing and manufacturing of three COVID-19 antigen tests. The RADx initiative rigorously reviews and selects innovative, highly accurate diagnostic technologies to move quickly through the development pipeline t

PRA Health Sciences, Inc. (NASDAQ: PRAH) announced today it has been selected by the Biomedical Advanced Research and Development Authority (BARDA) to be a member of its updated Clinical Studies Network (CSN).